Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Complix N.V. logo — Complix is a biopharmaceutical company leading the way in th...

Complix N.V.

Complix is a biopharmaceutical company leading the way in the use of biologics for challenging disease targets.

Founded 2008 Belgium Belgium 8 employees Grant Total: $21.90M Biotechnology, Health Care

General Information

Company Name Complix N.V.
Founded Year 2008
Location Belgium Belgium +2
Employees 8
Industries Biotechnology, Health Care
Funding Stage Grant
Social

Get notified when Complix N.V. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Complix N.V.

Complix N.V. is a biopharmaceutical company based in Belgium that is pioneering the use of biologics for challenging disease targets. The company was founded in 2008 and is dedicated to the discovery and development of protein therapeutics using its proprietary alphabody™ technology. Alphabodies, which are robust and versatile protein scaffolds unrelated to immunoglobulins, are inspired by naturally occurring motives. Complix has developed the proprietary Cell Penetrating Alphabody (CPAB) technology, allowing it to access a broad range of intracellular disease-related targets that are considered "intractable" by currently available drug formats, such as antibodies and small molecules. The company's most recent investment was a €1.20M grant investment received on 07 September 2020. This investment was made by Agentschap Innoveren & Ondernemen. Complix's focus on addressing challenging disease targets with its innovative biologic technology makes it an attractive prospect for potential venture capital investment. Its unique approach to developing protein therapeutics positions the company as a potentially disruptive force in the biotechnology and health care industries.

Taxonomy: biopharmaceutical company, biologics, protein therapeutics, alphabody technology, cell penetrating technology, intracellular disease, drug discovery, protein scaffolds, non-injectable routes, disease targets, therapeutic proteins, biotech, pharmaceutical research, innovation, technology platforms

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 07 Sep 2020
Grant •••••• 1 •••• •••• 14 Dec 2017
Series B •••••• 8
Investor Investor Investor Investor
•••• •••• 		26 Jun 2013
Series A •••••• - 02 Feb 2011
Series A •••••• - 10 Jun 2010

Complix N.V. Alternatives & Competitors

Complix N.V. vs
PROTEINA
PROTEINA Korea South

Our Protein-protein interaction (PPI) analysis platform enables quantitative measurements at the sin...

Series C
32 employees
Biotechnology, Health Care
Complix N.V. vs
RevolKa Ltd.
RevolKa Ltd. Japan

Contribute to the health and well-being of people by using our innovative AI assisted protein engine...

11 employees
Complix N.V. vs
Enifer
Enifer Finland

The brewers of PEKILO, the original mycoprotein. Sustainable protein is ready for scale!

34 employees

FAQ About Complix N.V.

Complix is a biopharmaceutical company leading the way in the use of biologics for challenging disease targets.
Complix N.V. was founded in 2008.
Complix N.V. is headquartered in Belgium.
Complix N.V. operates in the following industries: Biotechnology, Health Care.
Complix N.V. has approximately 8 employees.
Complix N.V. has completed 5 funding rounds, raising a total of $21.90M. The latest funding stage is Grant.
Top alternatives and competitors to Complix N.V. include PROTEINA, RevolKa Ltd., Enifer, Epinoma, Avilar Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Complix N.V. and PROTEINA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Complix N.V. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy